VIM and hepatocellular carcinoma: Moreover, morusin treatment also suppresses the metastatic capacity of the human hepatoma SK-Hep1 cell line, which may be biochemically associated with inhibition of STAT3 and NF-κB followed by the reduction of the expression of metastatic markers, such as vimentin, α2- and β1-integrins [34].